Mike Drummond

2020

Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

Nicod, E., Whittal, A., Drummond, M. & Facey, K., 20 Jul 2020, In: Orphanet Journal of Rare Diseases. 15, 189.

Research output: Contribution to journal › Editorial › peer-review

HTA’d in the USA: A Comparison of ICER in the United States with NICE in England and Wales

Thokala, P., Carlson, J. & Drummond, M., 26 Sept 2020, In: Journal of Managed Care and Specialty Pharmacy. 26, 9, p. 1162-1170 9 p.

Research output: Contribution to journal › Editorial › peer-review

Taking Steps Toward Transparency in Real-World Evidence Studies

Drummond, M., 1 Sept 2020, In: Value in Health. 23, 9, p. 1119 1 p.

Research output: Contribution to journal › Editorial › peer-review

Yes, Authorship Is Important

Drummond, M. & Daniel Mullins, C., 1 Jul 2020, In: Value in Health. 23, 7, p. 827-828 2 p.

Research output: Contribution to journal › Editorial › peer-review

2019

An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed?

Kanavos, P., Angelis, A. & Drummond, M. F., 14 Mar 2019, (E-pub ahead of print) In: European Journal of Health Economics. 20, 3, p. 329-332 4 p.

Research output: Contribution to journal › Editorial › peer-review

Open Access

File

"Back to the Future" with Value in Health

Drummond, M. F. & Mullins, C. D., 1 May 2019, In: Value in Health. 22, 5, p. 503-504 2 p.

Research output: Contribution to journal › Editorial › peer-review

Open Access

File

Is rate of return pricing a useful approach when value-based pricing is not appropriate?

Drummond, M. F. & Towse, A., 12 Aug 2019, In: European Journal of Health Economics. 4 p.

Research output: Contribution to journal › Editorial › peer-review

Open Access

File

2018

Does the approach to economic evaluation in health care depend on culture, values, and institutional context?

Torbica, A., Tarricone, R. & Drummond, M. F., 1 Jul 2018, In: European Journal of Health Economics. 19, 6, p. 769-774 6 p.

Research output: Contribution to journal › Editorial › peer-review

Open Access

File

2012

Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?

Drummond, M. F. & Towse, A., Feb 2012, In: European Journal of Health Economics. 13, 1, p. 1-5 5 p.

Research output: Contribution to journal › Editorial › peer-review

Special Issue: recommendations of the ISPOR-SMDM Joint Modeling Good Research Practices Task Force

Drummond, M., Helfand, M. & Mullins, C. D., 2012, In: Medical Decision Making. 32, 5, p. 653-655 3 p.

Research output: Contribution to journal › Editorial

2010

AHRQ Series Commentary 3: The United States addresses comparative effectiveness but not cost-effectiveness through the Effective Health-Care Program

Freemantle, N. & Drummond, M. F., May 2010, In: Journal of Clinical Epidemiology. 63, 5, p. 479-480 2 p.

Research output: Contribution to journal › Editorial › peer-review

2009

Rationing new medicines in the UK: A fair and consistent process is needed for dealing with absence of evidence (invited editorial)

Drummond, M. & Mason, A., 22 Jan 2009, In: British Medical Journal. 338, p. - 3 p., a3182.

Research output: Contribution to journal › Editorial › peer-review

2008

Cost-effectiveness analysis: An essential tool to inform public health policy in cervical cancer prevention - Foreword

Franco, E. L. & Drummond, M. F., 15 Sept 2008, In: Vaccine. 26, SUPPL.5, p. F1-F2 2 p.

Research output: Contribution to journal › Editorial › peer-review

2007

Evidence for coverage decisions: The need for a reality check

Drummond, M., 2007, In: Value in Health. 10, 5, p. 321 1 p.

Research output: Contribution to journal › Editorial › peer-review

Technology assessment in the German context

Drummond, M., Sept 2007, In: European Journal of Health Economics. 8, p. S3-S3 1 p.

Research output: Contribution to journal › Editorial › peer-review

2006

Assessing the quality of Swedish health economics research

Drummond, M. F., Botten, G., Hakkinen, U. & Pedersen, K. M., Dec 2006, In: Scandinavian journal of public health. 34, 6, p. 566-567 2 p.

Research output: Contribution to journal › Editorial › peer-review

Better analysis for better decisions: Has pharmacoeconomics come of age?

Drummond, M. & Sculpher, M., 2006, In: Pharmacoeconomics. 24, 2, p. 107-108 2 p.

Research output: Contribution to journal › Editorial › peer-review

Better analysis for better decisions - Facing up to the challenges

Drummond, M. F. & Sculpher, M. J., 2006, In: Pharmacoeconomics. 24, 11, p. 1039-1042 4 p.

Research output: Contribution to journal › Editorial › peer-review

2005

Taking clinical trials to task

Drummond, M., 2005, In: Value in Health. 8, 5, p. 517-518 2 p.

Research output: Contribution to journal › Editorial › peer-review

2004

Publication of pharmacoeconomic data submitted to reimbursement or clinical guidelines agencies

Mauskopf, J. & Drummond, M., 2004, In: Value in Health. 7, 5, p. 515-516 2 p.

Research output: Contribution to journal › Editorial › peer-review

2003

Grading systems for cost-effectiveness studies - Is the whole greater than the sum of the parts?

Stearns, S. C. & Drummond, M., Jan 2003, In: Medical Care. 41, 1, p. 13 3 p.

Research output: Contribution to journal › Editorial › peer-review

2002

A rational framework for decision making by the National Institute for Clinical Excellence (NICE)

Claxton, K., Sculpher, M. & Drummond, M., 31 Aug 2002, In: Lancet. 360, 9334, p. 711-715 5 p.

Research output: Contribution to journal › Editorial › peer-review

2001

Effectiveness, efficiency, and NICE - A NICE start but evidence costs money

Sculpher, M., Drummond, M. & O'Brien, B., 21 Apr 2001, In: British medical journal. 322, 7292, p. 943-944 2 p.

Research output: Contribution to journal › Editorial › peer-review

2000

Arthritis treatment outcomes: ACCESsing the data - Introduction

Sangha, O. & Drummond, M. F., Dec 2000, In: Rheumatology. 39, p. 12 2 p.

Research output: Contribution to journal › Editorial › peer-review

1997

Discussion: Challenges in the economic evaluation of incontinence services

Drummond, M. F., Dec 1997, In: Urology. 50, 6A, p. 108-108 1 p.

Research output: Contribution to journal › Editorial › peer-review

Should clinical trials with concurrent economic analyses be blinded?

Freemantle, N. & Drummond, M., 1 Jan 1997, In: Journal of American Medical Association. 277, 1, p. 63-64 2 p.

Research output: Contribution to journal › Editorial › peer-review

1996

Gene therapy: Socioeconomic and ethical issues a roundtable discussion

Hillman, A. L., Brenner, M. K., Caplan, A. L., Carey, J., Champey, Y., Culver, K. W., Drummond, M. F., Freund, D. A., Holmes, E. W., Kelley, W. N., Kolata, G., Levine, M. N., Levy, E., Schondelmeyer, S. W., Velu, T. & Wilson, J. M., 10 Jun 1996, In: HUMAN GENE THERAPY. 7, 9, p. 1139-1144 6 p.

Research output: Contribution to journal › Editorial › peer-review

1995